Skip to main content

Greiner Bio-One, Scienion, Genetix


Greiner Bio-One of Frickenhausen, Germany, and Scienion of Berlin have launched the High-Throughput Microarray Platform, a two-format, combined offering from both companies. The product line offers plastic slides with 12 arrays, and microplates with 96 wells for the parallel analysis of 12 or 96 arrays, respectively.

The HTA Plate format, containing four stripes of 24 wells, has low rims to facilitate printing of biolog-ical analytes and contains a removable washing unit to allow for increases in volume to accommodate hybridization and washing.

Scienion’s reagents and controls are bundled with the package, which will be marketed by both companies. Additionally, Scienion has adopted its sciFlexarrayer non- contact piezo-electric dispensing system, for loading both the slides and plates.

Pricing details were not disclosed.

Scienion is a 2000 spinoff from the Max Planck Institute for Molecular Genetics. Greiner Bio-One is the bioscience division of Greiner Bio-One International.

Genetix of New Milton, UK, last week announced the launch of aQu pins, a line of microarray pins manufactured from tungsten. The pins, the company said in a statement, can provide up to 20 million spots each and are compatible with major microarrayer print heads.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.